David T Howton - Net Worth and Insider Trading
David T Howton Net Worth
The estimated net worth of David T Howton is at least $5 Million dollars as of 2025-07-24. David T Howton is the SVP of Vertex Pharmaceuticals Inc and owns about 9,535 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $5 Million. David T Howton is the EVP, General Counsel of Sarepta Therapeutics Inc and owns about 31,871 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $424,522. David T Howton is also the COO of Solid Biosciences Inc and owns about 24,789 shares of Solid Biosciences Inc (SLDB) stock worth over $167,574. Details can be seen in David T Howton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David T Howton has not made any transactions after 2025-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David T Howton
David T Howton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David T Howton owns 3 companies in total, including Sarepta Therapeutics Inc (SRPT) , Vertex Pharmaceuticals Inc (VRTX) , and Solid Biosciences Inc (SLDB) .
Click here to see the complete history of David T Howton’s form 4 insider trades.
Insider Ownership Summary of David T Howton
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2020-06-22 | SVP & General Counsel |
| VRTX | Vertex Pharmaceuticals Inc | 2011-09-01 | SVP |
| SLDB | Solid Biosciences Inc | 2025-02-14 | See Remarks |
David T Howton Latest Holdings Summary
David T Howton currently owns a total of 3 stocks. Among these stocks, David T Howton owns 9,535 shares of Vertex Pharmaceuticals Inc (VRTX) as of September 1, 2011, with a value of $5 Million and a weighting of 88.48%. David T Howton owns 31,871 shares of Sarepta Therapeutics Inc (SRPT) as of June 22, 2020, with a value of $424,522 and a weighting of 8.26%. David T Howton also owns 24,789 shares of Solid Biosciences Inc (SLDB) as of February 14, 2025, with a value of $167,574 and a weighting of 3.26%.
Latest Holdings of David T Howton
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2011-09-01 | 9,535 | 476.95 | 4,547,718 |
| SRPT | Sarepta Therapeutics Inc | 2020-06-22 | 31,871 | 13.32 | 424,522 |
| SLDB | Solid Biosciences Inc | 2025-02-14 | 24,789 | 6.76 | 167,574 |
Holding Weightings of David T Howton
David T Howton Form 4 Trading Tracker
According to the SEC Form 4 filings, David T Howton has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 328 shares on September 1, 2011, which brought David T Howton around $14,527.
According to the SEC Form 4 filings, David T Howton has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the sale of 105,122 shares on June 22, 2020, which brought David T Howton around $18 Million.
According to the SEC Form 4 filings, David T Howton has made a total of 3 transactions in Solid Biosciences Inc (SLDB) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Solid Biosciences Inc is the sale of 5,561 shares on February 14, 2025, which brought David T Howton around $22,022.
Insider Trading History of David T Howton
- 1
David T Howton Trading Performance
David T Howton Ownership Network
Ownership Network List of David T Howton
Ownership Network Relation of David T Howton
David T Howton Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
David T Howton is the SVP & General Counsel of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, David T Howton made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net sale of 40,957 shares made by Ryan Edward Brown , a net sale of 25,500 shares made by Wigzell Hans Lennart Rudolf , and a net sale of 13,757 shares made by Bilal Arif .
In summary, during the past 3 months, insiders sold 0 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 99,057 shares of Sarepta Therapeutics Inc (SRPT) were sold and 37,038 shares were bought by its insiders, resulting in a net sale of 62,019 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
David T Howton Mailing Address
Above is the net worth, insider trading, and ownership report for David T Howton. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David T Howton's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
